中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自身免疫性肝炎发病机制研究进展

王倩怡 贾继东

引用本文:
Citation:

自身免疫性肝炎发病机制研究进展

详细信息
  • 中图分类号: R575.1

Advances in the pathogenesis of autoimmune hepatitis

  • 摘要: 自身免疫性肝炎的病因及发病机制尚未完全阐明,目前多数学者认为具有遗传易感性的个体在多种诱因作用下,自身免疫耐受机制遭到破坏,机体逐渐不能耐受自身抗原,从而导致出现疾病特异性的自身抗体并在肝脏内出现免疫细胞浸润。深入研究发病机制,有助于在诊断、治疗及预防上取得根本性突破。本文就自身免疫性肝炎发病机制的研究进展作一综述。

     

  • [1]Edward LK.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) :54-66.
    [2]Czaja AJ, Carpenter HA, Moore SB.HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients[J].Gut, 2007, 56 (10) :1471-1472.
    [3]Seki T, Ota M, Furuta S, et al.HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients[J].Gastroenterology, 1992, 103 (3) :1041-1047.
    [4]Pando M, Larriba J, Fernandez GC, et al.Pediatric and adult forms of type I autoimmune hepatitis in Argentina:evidence for differential genetic predisposition[J].Hepatology, 1999, 30 (6) :1374-1380.
    [5]Czaja AJ, Donaldson PT.Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis[J].Immunol Rev, 2000, 174:250-259.
    [6]Duarte-Rey C, Pardo AL, Rodriguez-Velosa Y, et al.HLA class II association with autoimmune hepatitis in Latin America:a meta-analysis[J].Autoimmun Rev, 2009, 8 (4) :325-331.
    [7]Qiu DK, Ma X.Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients[J].J Gastroenterol Hepatol, 2003, 18 (1) :63-67.
    [8]Czaja AJ, Carpenter HA.Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly[J].Hepatology, 2006, 43 (3) :532-538.
    [9]Bittencourt PL, Goldberg AC, Cancado EL, et al.Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and[J].Am J Gastroenterol, 1999, 94 (7) :1906-1913.
    [10]Djilali-Saiah I, Fakhfakh A, Louafi H, et al.HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis[J].J Hepatol, 2006, 45 (6) :844-850.
    [11]Ben-Ari Z, Czaja AJ.Autoimmune hepatitis and its variant syndromes[J].Gut, 2001, 49 (4) :589-594.
    [12]Suzuki Y, Ikeda K, Hirakawa M, et al.Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis[J].Dig Dis Sci, 2010, 55 (7) :2070-2076.
    [13]Agarwal K, Czaja AJ, Jones DE, et al.Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis[J].Hepatology, 2000, 31 (1) :49-53.
    [14]Umemura T, Ota M, Yoshizawa K, et al.Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese[J].Hepatol Res, 2008, 38 (7) :689-695.
    [15]Hiraide A, Imazeki F, Yokosuka O, et al.Fas polymorphisms influence susceptibility to autoimmune hepatitis[J].Am J Gastroenterol, 2005, 100 (6) :1322-1329.
    [16]Agarwal K, Czaja AJ, Donaldson PT.A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis[J].Tissue Antigens, 2007, 69 (3) :227-235.
    [17]Fan L, Tu X, Zhu Y, et al.Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary J Clini Hepatol, June 2011, Vol.27, No.6cirrhosis in the Chinese[J].J Gastroenterol Hepatol, 2005, 20 (2) :249-255.
    [18]Chen S, Zhao W, Tan W, et al.Association of TBX21 promoter polymorphisms with type 1 autoimmune hepatitis in Chinese[J].Hum Immuno, 2011, 72 (1) :69-73.
    [19]Jiang W, Anderson MS, Bronson R, et al.Modifier loci condition autoimmunity provoked by Aire deficiency[J].J Exp Med, 2005, 202 (6) :805-815.
    [20]Kerkar N, Choudhuri K, Ma Y, et al.Cytochrome P4502D6 (193-212) :a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J].J Immunol, 2003, 170 (3) :1481-1489.
    [21]Berry PA, Smith-Laing G.Hepatitis A vaccine associated with autoimmune hepatitis[J].World J Gastroenterol, 2007, 13 (15) :2238-2239.
    [22]Abraham C, Hart J, Locke SM, et al.A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis[J].Gastroenterology&Hepatology, 2008, 5 (3) :172-176.
    [23]Leonid B, Elena R, Ignacio S, et al.Autoimmune hepatitis and hypergammaglobulinemic purpura associated with herbal medicine use[J].IMAJ, 2008, 10 (5) :390-391.
    [24]Kerkar N, Choudhuri K, Ma Y, et al.Cytochrome P4502D6 (193-212) :a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J].J Immunol, 2003, 170 (3) :1481-1489.
    [25]Vergani D, Mieli-Vergani G.The impact of autoimmunity on hepatocytes[J].Semin Liver Dis, 2007, 27 (2) :140-151.
    [26]Holdener M, Hintermann E, Bayer M, et al.Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection[J].J Exp Med, 2008, 205 (6) :1409-1422.
    [27]Bogdanos DP, Lenzi M, Okamoto M, et al.Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51[J].Int J Immunopathol Pharmacol, 2004, 17 (1) :83-92.
    [28]Wies I, Brunner S, Henninger J.Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J].Lancet, 2000, 355 (9214) :1510-1515.
    [29]Jiang H, Chess L.Regulation of immune responses by T cells[J].N Engl J Med, 2006, 354:1166-1176.
    [30]Longhi MS, Hussain MJ, Mitry RR, et al.Functional study of CD4+CD25+regulatory T cells in health and autoimmune hepatitis[J].J Immunol, 2006, 176 (7) :4484-4491.
    [31]胥萍, 李明, 吴敏娟, 等.自身免疫性肝病相关抗体与CD4+CD25+high调节性T细胞的临床意义探讨[J].中国现代药物应用, 2008, 2 (3) :1-3.
    [32]Longhi MS, Ma Y, Mitry RR, et al.Effect of CD4+CD25+regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis[J].J Autoimmun, 2005, 25 (1) :63-71.
    [33]Okumura A, Ishikawa T, Sato S, et al.Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4 (+) CD25 (+) T cells in patients with autoimmune hepatitis[J].Hepatol Res, 2008, 38 (9) :896-903.
    [34]Longhi MS, Mitry RR.Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells[J].Hepatology, 2009, 50 (1) :130-142.
    [35]Longhi MS, Ma Y.Impairment of CD4 (+) CD25 (+) regulatory T-cells in autoimmune liver disease[J].J Hepatol, 2004, 41 (1) :31-37.
    [36]Yang XO, Pappu BP, Nurieva R, et al.T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma[J].Immunity, 2008, 28 (1) :29-39.
    [37]Shahrara S, Huang Q, Mandelin AM, et al.Th117 cells in rheumatoid arthritis[J].Arthritis Res Ther, 2008, 10 (4) :R93.
    [38]Kurasawa K, Hirose K, Sano H.Increased interleukin-17 production in patients with systemic sclerosis[J].Arthritis Rheum, 2000, 43 (11) :2455-2463.
    [39]Nielsen OH, Kirman I, Rfidiger N, et al.Upregulation of interleukin-12 and-17 in active inflammatory bowel disease[J].Scand J Gastroenterol, 2003, 38 (2) :180-185.
    [40]Lan RY, Salunga TL, Tsuneyama K, et al.Hepatic IL-17 responses in human and murine primary biliary cirrhosis[J].J Autoimmun, 2009, 32 (1) :43-51.
    [41]Harada K, Shimoda S, Sato Y, et al.Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis[J].Clin Exp Immunol, 2009, 157 (2) :261-270.
    [42]Yu H, Huang J, Liu Y, et al.IL-17 contributes to autoimmune hepatitis[J].J Huazhong Univ Sci Technolog Med Sci, 2010, 30 (4) :443-446.
    [43]Oo, Hubscher SG, Adams DH.Autoimmune hepatitis:new paradigms in the pathogenesis, diagnosis, and management[J].Hepatol Int, 2010, 4 (2) :475-493.
    [44]Nowak M, Stein-Streilein J.Invariant NKT cells and tolerance[J].Int Rev Immunol, 2007, 26 (1-2) :95-119.
    [45]Takahashi H, Oikawa T, Amano K, et al.Intrahepatic NKT cell and soluble CD1d have a significant role in the immuno-pathogenesis of AIH but not PBC[J].Hepatology, 2006, 44 (Suppl 1) :227A-228A.
    [46]Takeda K, Hayakawa Y, Van Kaer L, et al.Critical contribution of liver natural killer T cells to a murine model of hepatitis[J].Proc Natl Acad Sci U S A, 2000, 97 (10) :5498-5503.
    [47]Chung H, Watanabe T, Kudo M, et al.Identification and characterization of IgG4-associated autoimmune hepatitis[J].Liver Int, 2010, 30 (2) :222-231.
    [48]Lapierre P, Djilali-Saiah I, Vitozzi S, et al.A murine model of type 2 autoimmune hepatitis:xenoimmunization with human antigens[J].Hepatology, 2004, 39 (4) :1066-1074.
    [49]Lapierre P, Beland K, Djilali-Saiah I, et al.Type 2 autoimmune hepatitis murine model:the influence of genetic background in disease development[J].J.Autoimmun, 2006, 26 (2) :82-89.
    [50]Zierden M, Kuhnen E, Odenthal M, et al.Effects and regulation of autoreactive CD8+T cells in a transgenic mouse model of autoimmune hepatitis[J].Gastroenterology, 2010, 139 (3) :975-986.
  • 加载中
计量
  • 文章访问数:  2495
  • HTML全文浏览量:  22
  • PDF下载量:  841
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-04-13
  • 出版日期:  2011-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回